48 Followers SGX:T14 - Tianjin ZX USD (USD 0.865) TIANJIN ZHONG XIN PHARM GROUP
Sector: Health Technology, Industry: Pharmaceuticals: Other
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 0.865    -0.010 (-1.14%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

7 Aug 2020


Overview

7 Aug 2020

52 Wk Range: 0.505 - 0.99

Day's Range: 0.865 - 0.88

Last Volume: 282,800

Current Yield: 4.90%

Projected Yield: 4.99%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

7 Aug 2020

Metric T14 S.Median
Beta 0.84 0.11
VaR 21.1 50.46
E.Shortfall 26.88 77.86
Liquidity 521.44K 748.11K

Fundamental

7 Aug 2020

PE: 7.65

Market Cap: 665.9M

Price Over Book: 0.849

Price Over Sales: 0.68

Return On Assets: 7.7%

Return On Equity: 11.2%

Shares By Insiders: 76%

General

CEO: Yan Li

Founded Year: 1992

Headquarters: Tianjin

Employees: 4,720

Shares Outstanding: 768.9M

Sector: Health Technology

Industry: Pharmaceuticals: Other

Useful Links
Homepage

Description

Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.